AbbVie ($ABBV) is joining the rush to the Middle East with operations in Saudi Arabia. Its deal for the Arab Company for Pharmaceutical Products (Arabio) to manufacture Humira and other drugs in the kingdom is seen as a significant advance in the country's ability to manufacture biologics. AbbVie joins Pfizer ($PFE), which is building a plant there, while Sanofi ($SNY), Merck & Co. ($MRK) and others are establishing production and distribution operations throughout the Middle East. It is a region that is seen as one the emerging markets with the most potential. Story | More